Asset Details
Do you wish to reserve the book?
Desmopressin/indomethacin combination efficacy and safety in renal colic pain management: A randomized placebo controlled trial
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Desmopressin/indomethacin combination efficacy and safety in renal colic pain management: A randomized placebo controlled trial
Do you wish to request the book?
Desmopressin/indomethacin combination efficacy and safety in renal colic pain management: A randomized placebo controlled trial
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Desmopressin/indomethacin combination efficacy and safety in renal colic pain management: A randomized placebo controlled trial
2019
Overview
Renal colic is a prevalent cause of abdominal pain in the emergency department. Although non-steroidal anti-inflammatory drugs and opioids are used for the treatment of renal colic, some adverse effects have been reported. Therefore, desmopressin -a synthetic analogue of vasopressin- has been proposed as another treatment choice. In the present study, indomethacin in combination with nasal desmopressin was compared with indomethacin alone in the management of renal colic.
Included in the study were 124 patients with initial diagnosis of renal colic and randomized to receive indomethacin suppository (100 mg) with either desmopressin intranasal spray (4 puffs, total dose of 40 micrograms) and or placebo intranasal spray.
All the included patients were finally diagnosed with renal colic. There was no difference between the two groups in pain at the baseline (p = 0.4) and both treatments reduced pain successfully (p < 0.001). There was no significant difference between the two groups in pain reduction (p = 0.35).
While there was significant pain reduction in both patients groups, pain reduction of NSAIDs (e.g. indomethacin) in renal colic, does not significantly improve when given in combination with desmopressin.
Publisher
Elsevier Inc,Elsevier Limited
Subject
/ Deamino Arginine Vasopressin - standards
/ Deamino Arginine Vasopressin - therapeutic use
/ Dyspnea
/ Female
/ Humans
/ Indomethacin - therapeutic use
/ Kidneys
/ Male
/ Nonsteroidal anti-inflammatory drugs
/ Opioids
/ Pain
/ Pain Management - statistics & numerical data
/ Patient Safety - statistics & numerical data
/ Patients
/ Placebos
/ Ulcers
